Study Overview •HPTN 035 was a Phase II/IIb trial that evaluated the safety and effectiveness of the vaginal microbicides PRO 2000 (0.5 percent dose) and BufferGel for preventing male-to-female sexual transmission of HIV. • The study was not designed to...
About Health-e NewsHealth-e News is an award-winning print and TV health news service providing content to South African news outlets. It is also home to the OurHealth citizen journalism initiative. Read more.
Subscribe for weekly updatesGet the latest health news via email every week. Subscribe
Support usHelp sustain our work by making a donation. Find out more.